Basic Information
| LncRNA/CircRNA Name | uc004cox.4 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
| Regulatory Mechanism | Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Information of Cancer
| Cancer Name | bladder cancer |
| ICD-0-3 | C67 |
| Methods | Microarray, qPCR etc. |
| Sample | bladder cancer tissues |
| Expression Pattern | up-regulated |
| Function Description | In the training set, uc004cox.4 was up-regulated and GAS5 was down-regulated in BC patients. Moreover, the expression of urinary uc004cox.4 was an independent predictor for the recurrence of NMIBC patients. |
| Pubmed ID | 29516641 |
| Year | 2018 |
| Title | Cell-free lncRNA expression signatures in urine serve as novel non-invasive biomarkers for diagnosis and recurrence prediction of bladder cancer. |
External Links
| Links for uc004cox.4 | GenBank HGNC Noncode |
| Links for bladder cancer | Omim Cosmic |